Page last updated: 2024-08-22

aluminum sulfate and Glucose Intolerance

aluminum sulfate has been researched along with Glucose Intolerance in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Björklund, A; Grill, V; Hals, IK; Ludvigsson, J1
Balasuriya, C; Björklund, A; Casas, R; Grill, V; Hals, IK; Ludvigsson, J1
Achenbach, P; Agardh, CD; Bonifacio, E; Furmaniak, J; Hansen, JM; Hausmann, S; Krause, S; Landherr, U; Lernmark, A; Link, K; Lynch, KF; Powell, M; Rees-Smith, B; Ziegler, AG1

Trials

2 trial(s) available for aluminum sulfate and Glucose Intolerance

ArticleYear
Latent Autoimmune Diabetes in Adults: Background, Safety and Feasibility of an Ongoing Pilot Study With Intra-Lymphatic Injections of GAD-Alum and Oral Vitamin D.
    Frontiers in endocrinology, 2022, Volume: 13

    Topics: Adult; Aged; Alum Compounds; Diabetes Mellitus, Type 1; Feasibility Studies; Glucose Intolerance; Glutamate Decarboxylase; Humans; Insulin; Latent Autoimmune Diabetes in Adults; Middle Aged; Pilot Projects; Vitamin D

2022
GAD autoantibody affinity in adult patients with latent autoimmune diabetes, the study participants of a GAD65 vaccination trial.
    Diabetes care, 2014, Volume: 37, Issue:6

    Topics: Adult; Aged; Alum Compounds; Autoantibodies; C-Peptide; Diabetes Mellitus, Type 1; Disease Progression; Double-Blind Method; Female; Glucose Intolerance; Glutamate Decarboxylase; Humans; Insulin-Secreting Cells; Male; Middle Aged; Vaccination; Vaccines, Synthetic

2014

Other Studies

1 other study(ies) available for aluminum sulfate and Glucose Intolerance

ArticleYear
A 1-year pilot study of intralymphatic injections of GAD-alum in individuals with latent autoimmune diabetes in adults (LADA) with signs of high immunity: No safety concerns and resemblance to juvenile type 1 diabetes.
    Diabetes, obesity & metabolism, 2023, Volume: 25, Issue:11

    Topics: Adult; Autoantibodies; Diabetes Mellitus, Type 1; Glucose Intolerance; Glutamate Decarboxylase; Humans; Injections, Intralymphatic; Latent Autoimmune Diabetes in Adults; Leukocytes, Mononuclear; Middle Aged; Pilot Projects

2023